FDA approves new type of therapy to treat advanced urothelial cancer
FDA granted accelerated approval to Padcev, indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer
FDA granted accelerated approval to Padcev, indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer
Breast Cancer: New Horizons, Current Controversies is a comprehensive educational curriculum that encompasses the full range of breast cancer care. Topics include mechanisms of disease,…
Comorbid conditions complicate the care of patients with cancer and frequently cause exclusion of patients from clinical trials.
Comorbid conditions complicate the care of patients with cancer and frequently cause exclusion of patients from clinical trials.
Comorbid conditions complicate the care of patients with cancer and frequently cause exclusion of patients from clinical trials.
Breast Cancer: New Horizons, Current Controversies is a comprehensive educational curriculum that encompasses the full range of breast cancer care. Topics include mechanisms of disease,…
Dr Michael Serzan (Dana-Farber Cancer Institute, Boston, USA), Dr Javier Puente (Hospital Clínico San Carlos, Madrid, Spain), Dr Guillermo de Velasco (Un
We’re excited to join this incredible initiative! This organization’s mission is very important to us and we’re proud to help them make a difference. Please…
Breast Cancer: New Horizons, Current Controversies is a comprehensive educational curriculum that encompasses the full range of breast cancer care. Topics include mechanisms of disease,…
Breast Cancer: New Horizons, Current Controversies is a comprehensive educational curriculum that encompasses the full range of breast cancer care. Topics include mechanisms of disease,…
We’re excited to join this incredible initiative! This organization’s mission is very important to us and we’re proud to help them make a difference. Please…